arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

ASSEMBLY BIOSCIENCES, INC.

ASMB
$26.68 ▲ +0.18 (+0.68%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
20 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
38
Health
Weak
Bearish
auto_awesome

Analytical Summary

ASSEMBLY BIOSCIENCES, INC. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $299.1M
Dividend Yield
Revenue Growth 153.5%
Op. Margin -16.8%
ROIC -5.9%
FCF / Share $-3.67
Trailing P/E
Price / Book 2.1x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

20-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$72.30M
↑ +153.5%
Net Income Profit after all expenses
$-6.12M
↑ +84.8%
Operating Margin Operating profit as % of sales
-16.8%
↑ +89.5% 11th
FCF / Share Free cash flow per share
$-3.67
↑ +56.9%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
11
Returns
40
Cash Quality
97

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 70 quarters